The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Collecting duct-specific deletion of peroxisome proliferator-activated receptor γ blocks thiazolidinedione-induced fluid retention
Open accessAbstract
The peroxisome proliferator-activated receptor subtype γ (PPARγ) ligands, namely the synthetic insulin-sensitizing thiazolidinedione (TZD) compounds, have demonstrated great potential in the treatment of type II diabetes. However, their clinical applicability is limited by a common and serious side effect of edema. To address the mechanism of TZD-induced edema, we generated mice with collecting duct (CD)-specific disruption of the PPARγ gene. We found that mice with CD knockout of this receptor were resistant to the rosiglitazone- (RGZ) induced increases in body weight and plasma volume expansion found in control mice expressing PPARγ in the CD. RGZ reduced urinary sodium excretion in control and not in conditional knockout mice. Furthermore, RGZ stimulated sodium transport in primary cultures of CD cells expressing PPARγ and not in cells lacking this receptor. These findings demonstrate a PPARγ-dependent pathway in regulation of sodium transport in the CD that underlies TZD-induced fluid retention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,047
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Nesto, R. W., Bell, D., Bonow, R. O., Fonseca, V., Grundy, S. M., Horton, E. S., Le Winter, M., Porte, D., Semenkovich, C. F., Smith, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 829
Nonhypoglycemic Effects of Thiazolidinediones
Parulkar, A. A., Pendergrass, M. L., Granda-Ayala, R., Lee, T. R., & Fonseca, V. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00014 · Cited by 412
Gilde, A. J., van der Lee, K. A. J. M., Willemsen, P. H. M., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B., & van Bilsen, M. (2003) · Circulation Research · doi:10.1161/01.res.0000060700.55247.7c · Cited by 399
Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y.-H., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368
Self-citationPeroxisome proliferator‐activated receptors in the cardiovascular system
Bishop‐Bailey, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703149 · Cited by 363
Diep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 345
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Evaluation of the electroinjection method for introducing proteins into living cells
Wilson, A. K., Horwitz, J., & De Lanerolle, P. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.260.2.c355 · Cited by 303
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
Guan, Y., Zhang, Y., Davis, L., & Breyer, M. D. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.6.f1013 · Cited by 226
Inoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 199
Ryan, M. J., Didion, S. P., Mathur, S., Faraci, F. M., & Sigmund, C. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000116303.71408.c2 · Cited by 184
Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney
Yang, T., Michele, D. E., Park, J., Smart, A. M., Lin, Z., Brosius, F. C., Schnermann, J. B., & Briggs, J. P. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f966 · Cited by 162
Self-citationCharacterization of renin activity in brown adipose tissue
Shenoy, U., & Cassis, L. A. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.3.c989 · Cited by 135
Song, J., Knepper, M. A., Hu, X., Verbalis, J. G., & ECELBARGER, C. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058008 · Cited by 127
Yoshimoto, T., Naruse, M., Nishikawa, M., Naruse, K., Tanabe, A., Seki, T., Imaki, T., Demura, R., Aikawa, E., & Demura, H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.6.e989 · Cited by 117
Hong, G., Lockhart, A., Davis, B., Rahmoune, H., Baker, S. F., Liang, Y. S., Thompson, P., Shou, Y., O’Shaughnessy, K. M., Ronco, P. M., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0181fje · Cited by 110
Walker, A. B., Naderali, E. K., Chattington, P., Buckingham, R. E., & Williams, G. (1998) · Diabetes · doi:10.2337/diabetes.47.5.810 · Cited by 106
Zanchi, A., Chioléro, A., Maillard, M. P., Nussberger, J., Brunner, H., & Burnier, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031526 · Cited by 99
Peroxisome Proliferator‐Activated Receptors and Lipid Metabolisma
KELLER, H., Mahfoudi, A., Dreyer, C., Hihi, A. K., Medin, J. A., Ozato, K., & Wahli, W. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb32279.x · Cited by 90
Reynolds, S. D., Giangreco, A., Hong, K. U., McGrath, K. E., Ortiz, L. A., & Stripp, B. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00203.2004 · Cited by 86
Füchtenbusch, M., Standl, E., & Schatz, H. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-7737 · Cited by 83
Pulmonary Edema Associated with Rosiglitazone and Troglitazone
Thomas, M. L., & Lloyd, S. J. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10132 · Cited by 78
Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature
Guan, Y., Zhang, Y., Schneider, A., Davis, L. S., BREYER, R. M., & Breyer, M. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0025.2001 · Cited by 76
Iwasaki, K., Zhang, R., Perhonen, M. A., Zuckerman, J. H., & Levine, B. D. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00613.2002 · Cited by 76
Chen, L., Yang, B., McNulty, J. A., Clifton, L. G., Binz, J. G., Grimes, A. M., Strum, J. C., Harrington, W. W., Chen, Z., Balon, T. W., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074088 · Cited by 74
Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.
Cheng-Lai, A., & Levine, A. (2002) · PubMed · Cited by 36
Bando, Y., Ushiogi, Y., Okafuji, K., et al. (1999) · Journal of International Medical Research · doi:10.1177/030006059902700201 · Cited by 26
Troglitazone Inhibits Bicarbonate Secretion in Rat and Human Duodenum
Hosokawa, M., Tsukada, H., Fukuda, K., Oya, M., Onomura, M., Nakamura, H., Kodama, M., Yamada, Y., & Seino, Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35008-6 · Cited by 24
Yang, B., Clifton, L. G., McNulty, J. A., Chen, L., Brown, K. K., & Baer, P. G. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200309000-00016 · Cited by 22
Ross, M. G., & Idah, R. (2004) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050310001650770 · Cited by 14
Cited by
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,443
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD
Gross, B., Pawlak, M., Lefebvre, P., & Staels, B. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.135 · Cited by 778
Metadata
- Authors
- Zhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzalez, F. J., & Yang, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-06-14
- Volume
- 102
- Issue
- 26
- Pages
- 9406-9411
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060060473
- Cited by
- 317
- References
- 41
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.